Why the study?
Advances in imaging and targeted therapies have led to a paradigm shift in the management of recurrent pericarditis.
Cardiac magnetic resonance imaging and interleukin-1 blockers play a key role in the tailored therapy of recurrent pericarditis.
May guide tailored recurrent pericarditis management; leaves open need for RCTs validating CMR and IL-1 blocker strategies.
Advances in imaging and targeted therapies have led to a paradigm shift in the management of recurrent pericarditis. This narrative review summarizes the established and emerging data on the diagnosis and treatment of recurrent pericarditis with special emphasis on the role of cardiac magnetic resonance imaging and interleukin-1 blockers in the current era of tailored therapy for recurrent pericarditis.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: